International Conference on Advances in Hematology and Oncology

Transcription

1 International Conference on Advances in Hematology and Oncology The Coeur d Alene Resort, Coeur d Alene, Idaho. August 28-29, BINAYTARA FOUNDATION

2 Chair s Message Dear Colleagues, On behalf of the organizing committee, I welcome you to participate in the International Conference on Advances in Hematology and Oncology on August 28-29, 2016 at The Coeur d Alene Resort, Coeur d Alene, Idaho. This conference has become an hallmark of the impact that the Binaytara Foundation has made in inland Northwest, gathering every year experts who present updated results of translational and clinical research in hematology and oncology and provide valuable opportunities to discuss and understand what can be offered to patients whose cure remains the main goal for all of us. This year the Conference has grown into an international venue where young and senior investigators have the chance to share their own research with colleagues from all over the world. The Conference will focus on the discoveries that have led to the development of new biomarkers for patient-specific diagnostic or prognostic stratification, and of new treatments based on targeting driving mutations, or molecules tested in phase 1 clinical trials, or immunotherapy strategies that have strengthened the anticancer activity beyond chemo-radiotherapy. The mission of the Binaytara Foundation that supports this conference, joined with enthusiasm by multiple generous sponsors, is to make a difference in people s life by promoting medical education and developing clinical policies and infrastructures. This conference has the goal to make every participant actively engaged in the growth of our knowledge of hematology and oncology and to contribute to the mission of the Binaytara Foundation. The Coeur d Alene Resort offers a spectacular landscape in one of the most beautiful lakes of the Northwest and will allow the participants to enjoy a magical blend of science and beauty. We really hope that you and your colleagues will join us and look forward to seeing each of you at Coeur d Alene. Damiano Rondelli, MD Chair Michael Reese Professor of Hematology Chief, Division of Hematology/Oncology I Director, Blood & Marrow Transplant University of Illinois Hospital & Health Sciences System Target Audience. Hematologists. Oncologists. Surgeons. Radiation Oncologists. Primary Care Providers. Nurses. Oncology Pharmacists. Basic Science and Clinical Researchers

3 Educational Objectives At the conclusion of this activity, participants will be able to: a) Recognize factors that affect the diagnosis, staging, and prognosis of patients with hematologic malignancies and solid tumors b) Explain indications and contraindications of treatments used for hematologic malignancies and solid tumors c) Discuss emerging therapeutic options for treating patients with hematologic malignancies and solid tumors with colleagues and patients d) Interpret and practice relevant data presented at ASCO 2015 meeting. CME Credit The Ada Canyon Medical Education Consortium is accredited by the Idaho Medical Association and the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Ada Canyon Medical Education Consortium designates this live activity for a maximum of AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity. Abstract Submission Guideline Abstract Submission Deadline: Tuesday, June 30th, 2015, 11:59 PM PST Abstract Decision: Authors will be notified of acceptance or rejection via within 4 weeks of submission. We will accept abstracts in the following categories: 1. Basic science research 2. Clinical research 3. Case reports 4. Health outcome research Access the abstract submission guideline here - your abstract to hemeonc@binayfoundation.org Accepted abstracts will be published in the Anticancer Research Journal. Register online at

4 Program Agenda August 28, 2015 Panel session on myeloid neoplasms Acute myeloid leukemia new updates - 9:30 10:05 am Speaker: Dr. Roland Walter Changing scenarios in the treatment of Philadelphia negative myeloproliferative neoplasms - 10:05 10:40 am Speaker: Dr. Damiano Rondelli Panel discussion 10:40 11:00 am Panel session on other lymphoid neoplasms Updates in multiple myeloma 11:00 11:35 pm Speaker: Dr. Shaji Kumar CLL treatment strategies in the era of novel agents 11:35 12:10 pm Speaker: Dr. Farhad Ravandi Panel discussion 12:10 12: 30 pm Lunch/Networking/Poster session 12:30 1:30 pm Panel session on Breast cancer Considerations in breast conservative surgery - 1:30 2:05 pm Speaker: Dr. Sallee Jones Evolution in therapy of metastatic breast cancer - 2:05 2:40 pm Speaker: Dr. Mohammad Jahanzeb Panel discussion 2:40 3:00 pm Panel session on Head and Neck cancer/melanoma Neoadjuvant and adjuvant therapy considerations in Head and Neck cancer - 3:00 3:35 pm Speaker: Dr. Prakash Neupane Metastatic malignant melanoma ipilimumab and beyond - 3:35 4:10 pm Speaker: Dr. John Thompson Updates in Glioblastoma multiforme 4:10 4:40 pm Speaker: Dr. Sarah Taylor Panel discussion 4:40 5:00 pm Abstract sessions 5:00 6:00 pm Register online at

5 August 29, 2015 Panel session on Lymphomas Management of follicular lymphomas new updates 8:00 8:35 am Speaker: Dr. Binay Shah High risk diffuse large B cell lymphoma Management approach 8:35 9:10 pm Speaker: Dr. Parameswaran Venugopal Panel discussion 9:10 9:30 am Panel session on Thoracic malignancies Non small cell lung cancer Using molecular biology for advanced first line and progressive disease treatment 9:30 10:05 am Speaker: Dr. Heather Wakelee Immunotherapy in advanced lung cancer - 10:05 10:40 am Speaker: Dr. Arvind Chaudhry Panel discussion 10:40 11:00 am Panel session on GI malignancies Metastatic colon cancer Why choices matter in bettering outcomes - 11:00 11:35 am Speaker: Dr. Axel Grothey Recent advances in management of advanced pancreatic cancer - 11:35 12:10 pm Speaker: Dr. Arkadiusz Dudek Panel discussion 12:10 12:30 pm Lunch/Abstract session 12:30 1:30 pm Oral abstract session 1:30 2:30 pm Panel session on GU malignancies Metastatic prostate cancer Management in the era of novel agents - 2:30 3:05 pm Speaker: Dr. Evan Yu Radiotherapy in prostate cancer recent advances - 3:05 3:40 pm Speaker: Dr. Karie-Lynn Kelly Panel discussion 3:40 4:00 pm Register online at

6 Faculty Axel Grothey, M.D. Professor of Oncology Mayo Clinic College of Medicine John A. Thompson, M.D. University of Washington Shaji Kumar, M.D. Mayo Clinic College of Medicine Farhad Ravandi, M.D., M. D. Anderson Cancer Center, Texas Damiano Rondelli, M.D. University of Illinois at Chicago Arkadiusz Dudek, M.D. University of Illinois at Chicago (UIC) Parameswaran Venugopal, M.D. Rush University Medical Center Sarah Taylor, M. D. University of Kansas Medical Center Evan Y. Yu, M.D. Associate University of Washington School of Medicine Heather Wakelee, M.D. Associate Stanford University Medical Center Karie-Lynn Kelly, M.D. Radiation Oncologist Spokane CyberKnife & Radiation Oncology Prakash Neupane, M.D. Assistant University of Kansas Medical Center Binay Shah, M. D. Medical Oncologist/Hematologist St. Joseph Regional Cancer Center and Blood Institute Sallee Jones, D. O. Surgeon St. Joseph Regional Medical Center Arvind Chaudhry, M.D., PhD Medical Oncologist / Hematologist Spokane Valley Cancer Center Brian Samuels, M. D. Medical Oncologist / Hematologist Northwest Oncology/Spokane Valley Cancer Center Mohammad Jahanzeb, MD, FACP Professor of Clinical Medicine, Hematology/Oncology University of Miami Miller School of Medicine Somasundaran Subramaniam, M.D. Hematologist/Oncologist Swedish Cancer Institute in Seattle Juan Mejia, M.D. Surgeon, Liver and Pancreas Surgery services Providence Health and Services, Spokane Dinesh Pendharkar, M.D. Consultant, Medical Oncology Asian Institute of Oncology, Mumbai, India.

7 Accommodation A limited number of rooms have been booked at the Coeur d Alene resort for the conference attendees. All reservations should be made by July 18th, 2015 to receive the discounted rate listed below. Please contact the hotel at the address below to reserve your room. The Coeur d Alene resort 115 South Second Street, Coeur d Alene, ID Direct: Reservations: RATES Lake Tower - $ /night Park Tower - $ /night North Wing - $ /night Transportation The Spokane International Airport (GEG) is less than 30 minutes drive from the conference venue. Ground Transportation - The Coeur d Alene resort currently provides 6-passenger LimoVan service to and from the Spokane International Airport. This service is available with twenty-four (24) hour advanced reservations. The current fee is $69.00 per person, round trip; $10.00 per child ages 0 11, round trip. An 8-passenger stretch limousine and a 36-passenger Motorcoach are also available. Please inquire regarding rates and additional services. The city is also well served by taxi cabs. Rental car services are also located at the airport About Binaytara Foundation (BTF) The Binaytara Foundation (BTF) is a 501(c)3 non profit established in 2007 with the goal of promoting health and education in resource poor communities. BTF has a special consultative status with the United Nations Economic and Social Council (ECOSOC). Mission Statement : The Binaytara Foundation seeks to improve healthcare in resource poor communities and improve cancer care worldwide by collaborating with national and international organizations to: develop healthcare manpower in underserved areas; improve access to cancer care by establishing direct care facilities and services,; promote the practice of evidence based medicine by providing research grants to young physicians and healthcare providers in training; improve knowledge and competence of healthcare professionals by offering them continuing educational materials though live and virtual meetings, webinars, and other educational forums.

8 Full Name Title/Designation Affiliation Address Phone Registration Fees : Physician $300 if registered by July 30th, $350 if registered after July 30th. RN/NP/PA/PharmD $125 if registered by July 30th, $175 if registered after July 30th. Researcher/fellow/resident $125 if registered by July 30th, $175 if registered after July 30th. Student $75 if registered by July 30th, $125 if registered after July 30th. Industry $350 if registered by July 30th, $400 if registered after July 30th. Make Check payable to Binaytara Foundation Pay online with credit or debit card - Or mail the registration form along with payment to: Binaytara Foundation 3502 Quailridge Drive Clarkston, WA, Registration form International conference on Advances in Hematology and Oncology August 28-29, 2015 Register online at